| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ß+/CD4+ Large Granular Lymphocytosis
















From the Serviço de Hematologia Clinica,* Unidade de Citometria, Hospital Geral de Santo Antonio, Porto, Portugal; the Servicio de Citometria,
Universidad de Salamanca, Salamanca, Spain; the Centro de Investigación del Cáncer,
Salamanca, Spain; and the Servicio de Hematología,
Hospital Universitario de Salamanca, Salamanca, Spain
Large granular lymphocyte (LGL) leukemia is a well-recognized disease of mature T-CD8+ or less frequently natural killer cells; in contrast, monoclonal expansions of CD4+ T-LGL have only been sporadically reported in the literature. In the present article we have explored throughout a period of 56 months the incidence of monoclonal expansions of CD4+ T-LGL in a population of 2.2 million inhabitants and analyzed the immunophenotype and the pattern of cytokine production of clonal CD4+ T cells of a series of 34 consecutive cases. Like CD8+ T-LGL leukemias, CD4+ T-LGL leukemia patients have an indolent disease; however, in contrast to CD8+ T-LGL leukemias, they do not show cytopenias and autoimmune phenomena and they frequently have associated neoplasias, which is usually determining the clinical course of the disease. Monoclonal CD4+ T-LGLshowed expression of TCR
ß, variable levels of CD8 (CD8-/+dim) and a homogeneous typical cytotoxic (granzyme B+, CD56+, CD57+, CD11b+/-) and activated/memory T cell (CD2+bright, CD7-/+dim, CD11a+bright, CD28-, CD62L- HLA-DR+) immunophenotype. In addition, they exhibited a Th1 pattern of cytokine production [interferon-
++, tumor necrosis factor-
++, interleukin (IL-2)-/+, IL-4-, IL-10-, IL-13-]. Phenotypic analysis of the TCR-Vß repertoire revealed large monoclonal TCR-Vß expansions; only a restricted number of TCR-Vß families were represented in the 34 cases analyzed. These findings suggest that monoclonal TCR
ß+/CD4+/NKa+/CD8-/+dim T-LGL represent a subgroup of monoclonal LGL lymphoproliferative disorders different from both CD8+ T-LGL and natural killer cell-type LGL leukemias. Longer follow-up periods are necessary to determine the exact significance of this clonal disorder.
This article has been cited by other articles:
![]() |
P. Garrido, F. Ruiz-Cabello, P. Barcena, Y. Sandberg, J. Canton, M. Lima, A. Balanzategui, M. Gonzalez, M. A. Lopez-Nevot, A. W. Langerak, et al. Monoclonal TCR-V 13.1+/CD4+/NKa+/CD8 /+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin Blood, June 1, 2007; 109(11): 4890 - 4898. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lima, J. Almeida, A. G. Montero, M. d. A. Teixeira, M. L. Queiros, A. H. Santos, A. Balanzategui, A. Estevinho, M. d. C. Alguero, P. Barcena, et al. Clinicobiological, Immunophenotypic, and Molecular Characteristics of Monoclonal CD56-/+dim Chronic Natural Killer Cell Large Granular Lymphocytosis Am. J. Pathol., October 1, 2004; 165(4): 1117 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herling, J. D. Khoury, L. T. Washington, M. Duvic, M. J. Keating, and D. Jones A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories Blood, July 15, 2004; 104(2): 328 - 335. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |